Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-03-14
2009-08-18
Morris, Patricia L (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07576219
ABSTRACT:
This invention provides a crystalline S-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, theremostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.
REFERENCES:
patent: 6369085 (2002-04-01), Cotton et al.
patent: 6627646 (2003-09-01), Bakale et al.
patent: 2004/099182 (2004-11-01), None
patent: 2005/011692 (2005-02-01), None
patent: 2006/120520 (2006-11-01), None
patent: WO 2006/120520 (2006-11-01), None
patent: 2007/049914 (2007-05-01), None
Chemical & Engineering News, Feb. 2003, 32-35.
Brittain et al., “Polymorphism in Pharmaceutical, etc.,” NY: Marcel Dekker, Inc., 1999, 1-2, 125-181, 183-226.
US Pharmacopia #23, National Formulary #18 (1995), 1843-1844.
Concise Encyclopedia Chemistry, NY: Walter de Gruyter Berlin, 1994, 872-873.
Vippagunta et al., “Crystalline Solids”, Advanced Drug Delivery Reviews 48 (2001) 3-26.
Doelker, “Physiochemical behavior, etc.,” S.T.P. Pharma Pratiques (1999), 9(5), 399-409 and english translation pp. 1-39.
CMU Pharmaceutical polymorphism, intenet p. 1-3 (2002) (printout Apr. 3, 2008).
Singhal et al., “Drug polymorphism, etc.,” Advanced drug delivery reviews 56, 335-347 (2004).
Caira, “Crystalline Polymorphism of Organic Compounds”, Topics in Current Chemistry, 198, Berlin Heidlberg: Spring Verlag 1998, 184-208.
Muzaffar et al., Polymorphism and Drug Availability, etc., J of Pharm. (Lahore), 1979, 1(1), 59-66.
Jain et al., “Polymorphism in Pharmacy”, Indian Drugs, 1986, 23(6), 315-329.
Taday et al., “Using Terahertz, etc.,” J. of Pharm. Sci.., 92(4), 2003, 831-838.
Otsuka et al., “Effect of Polymorphis Forms, etc.,” Chem. Pharm. Bull. 47(6) 852-856 (1999).
Ha Tae Hee
Kim Eun Young
Kim Won Jeoung
Kim Young Hoon
Lee Gwan Sun
Hanmi Pharm. Co., Ltd
Morris Patricia L
Sughrue & Mion, PLLC
LandOfFree
Crystalline S-omeprazole strontium hydrate, method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline S-omeprazole strontium hydrate, method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline S-omeprazole strontium hydrate, method for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4066362